ALBANY, N.Y, May 4, 2021 /PRNewswire/ — The geriatric population has increased phenomenally over the years. The expanding prevalence of many diseases across the geriatric populace is expected to bring good growth opportunities for the periodontal therapeutics market. According to the World Health Organization (WHO), nearly 3.5 bn people are affected by oral diseases. The WHO also states that more than 10 percent of the global population is affected by severe periodontal diseases.
Periodontal disease can be described as the infection of the tissues that hold the teeth in place. It is caused by improper flossing habits and bad brushing habits. These bad habits lead to the formation of plaque, a sticky film of bacteria to build upon the teeth, which leads to periodontal disease. Smoking is the main cause of bacteria formation and the rising number of smokers is serving as a vital trigger for periodontal disease. Thus, all these factors bode well for the growth of the periodontal therapeutics market.
Request for Analysis of COVID-19 Impact on Periodontal Therapeutics Market –https://www.transparencymarketresearch.com/covid19.php
Transparency Market Research (TMR) estimates the periodontal therapeutics market to record a CAGR of 8.8 percent during the tenure of 2019-2027. The global periodontal therapeutics market was valued at US$ 537 mn in 2019 and is extrapolated to reach US$ 1.1 bn by the end of the forecast period that is 2027.
The reimbursement policies by the…
